Psoriatic arthritis trials in Czechia

In Czechia 9 Also abroad 116

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Brno, Brno-Židenice, Hlučín, Novy Hradec Kralove, Olomouc, Prague, Prague 1, Prague 11, Prague 2, Prague 4, Praha 4, Trebovice, Uherské Hradiště
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
Phase 2Taking people
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Where
Brno, Hlučín, Uherské Hradiště, Zlín
Age
18 years and over
People
300 worldwide
Run by
AbbVie
See details and how to joinNCT06865105
Phase 1Taking people
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Where
Brno, Hlučín, Ostrava, Uherské Hradiště
Age
18 years and over
People
392 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT07290036
Phase 3Taking people
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Where
Brno, Prague
Age
1 year to 18 years
People
190 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT03773965
Phase 3Taking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
Age
18 years and over
People
1,088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
Phase 3Taking people
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Where
Olomouc, Prague
Age
5 years to 17 years
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 3Not yet taking people in Czechia
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
Where
Břeclav, Brno-Sever, Butovice, Moravska Ostrava A Privoz, Prague, Prague 11, Prague 2, Praha 4, Praha 4-Krc, Zlín
Age
18 years and over
People
948 worldwide
Run by
MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00 · EU 2025-522471-28-00
No phaseTaking people
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Where
Ostrava, Pilsen
Age
18 years to 75 years
People
1,200 worldwide
Run by
AbbVie
See details and how to joinNCT06764693